Source Paper
Yu Zhou, Jaejoon Won, Mikael Guzman Karlsson, Miou Zhou, Thomas Rogerson et al.
Nature Neuroscience • 2009
Objective: To determine whether inactivation of lateral amygdala neurons transfected with HSV-CREB disrupts auditory fear conditioning memory by measuring freezing behavior during tone presentation
This is a Auditory Fear Conditioning protocol using mouse as the model organism. The procedure involves 14 procedural steps, 7 equipment items, 6 materials. Extracted from a 2009 paper published in Nature Neuroscience.
Model and subjects
mouse • Not specified • Not specified • Not specified • Not specified • Multiple groups (n values range from 12-17 per group)
Study window
~3 day study window | ~109.5 hours hands-on
Core workflow
Viral vector preparation and microinjection • Cannula placement verification • Verify CREB expression increase
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Prepare HSV-CREB or HSV-LacZ viral vectors. Microinject viruses bilaterally into lateral amygdala of mice approximately 3 days before tone fear conditioning.
Note: Approximately 20% of lateral amygdala neurons were transfected with either virus. No significant difference in infection rates between HSV-CREB (18±3%) and HSV-LacZ (21±4%, n=4 mice per group, P>0.05)
“These viruses were microinjected into lateral amygdala, which is essential for auditory Pavlovian fear-conditioning. Histological staining with a GFP antibody revealed that ~20% of lateral amygdala neurons were transfected with either virus”
Confirm bilateral cannula placements in basolateral complex of amygdala using crystal violet staining. Only include mice with correct bilateral placements in analysis.
Note: Only mice with bilateral placements in basolateral complex included in analysis
“Cannula placement was confirmed with crystal violet staining at the end of each experiment. Only those mice with bilateral placements in the basolateral complex of the amygdala were included in analysis”
Perform western blot analysis to confirm that HSV-CREB viral transfection increased CREB levels in amygdala and that HSV-LacZ had no detectable effect on CREB expression.
Note: HSV-CREB transfection increased CREB levels; HSV-LacZ had no detectable effect
“western blot analyses showed that HSV-CREB viral transfection increased CREB levels in the amygdala; Transfection with HSV-LacZ had no detectable effect on CREB expression”
Perform whole-cell patch clamp recordings in visually identified GFP+ neurons and GFP− neighboring cells from HSV-CREB or HSV-LacZ mice. Administer allatostatin (AL) and measure membrane potential changes, spike current threshold, and input resistance.
Note: AL administration caused membrane potential to become more negative in GFP+ neurons (-5.9±1.2 mV, t=3.73, P<0.01) but had no effect on GFP− cells (-0.3±0.9 mV). AL increased spike current threshold (600±210% of baseline, t=2.33, P<0.05) and decreased input resistance (51±12% of baseline, t=3.96, P<0.01) in GFP+ neurons only.
“AL administration quickly and reversibly caused the membrane potential to become more negative (−5.9 ± 1.2 mV, t = 3.73, P < 0.01) in GFP + neurons, but had no effect on GFP − neighboring cells”
Conduct tone fear conditioning approximately 3 days after viral injection. Expose mice to tone-shock pairings during training session.
Note: Training occurs ~3 days after viral microinjection
“both virus preparations were micro-infused bilaterally into the lateral amygdala ~3 days before tone fear conditioning”
Conduct memory retrieval test 24 hours after conditioning. Measure percentage of time mice spend freezing during tone presentation. Infuse allatostatin (10 µM, 0.5 µl) or vehicle bilaterally into lateral amygdala approximately 30 minutes before testing.
Note: HSV-CREB mice treated with AL showed less freezing (41.4%±3.7%, t=2.58, P<0.05) than HSV-CREB mice treated with saline (65.3%±8.5%). AL had no effect on HSV-LacZ mice freezing.
“Memory for tone conditioning was assessed by measuring the percentage of time the mice spent freezing during a tone presentation conducted 24 h after conditioning. To test the impact of inactivating transfected neurons, AL (10 µM, 0.5 µl) or vehicle were infused bilaterally into the lateral amygdala ~30 min before the retrieval of auditory fear memory”
In separate groups, infuse allatostatin or vehicle into lateral amygdala and wait 4 hours (instead of 30 minutes) before testing tone conditioning to determine duration of AL effects.
Note: AL infusion 4 hours before testing had no effect on retrieval, indicating AL effects last at least 30 minutes but no longer than 4 hours
“we also infused AL or vehicle into the lateral amygdala of separate groups of mice and waited 4 h (instead of 30 min) before testing tone conditioning. Our results showed that AL infusion 4 h before testing had no effect on retrieval”
Repeat memory retrieval test 24 hours after first test. Reverse treatments so mice that received AL in first test receive vehicle in second test and vice versa.
Note: HSV-CREB mice treated with AL in test 1 (50.7%±5.7% freezing) showed normal freezing in test 2 (67.1%±5.1%, t=2.14, n=15, P<0.05) when treated with saline. HSV-CREB mice treated with saline in test 1 (71.1%±4.8%) showed memory impairment in test 2 (47.3%±5.8%, t=3.17, n=17, P<0.01) when treated with AL.
“we repeated the experiment just described, but this time added a second test 24 h after the first test. In the second test we reversed the treatments so that mice that got AL in the first test got VEH in the second test”
Conduct tone fear conditioning with allatostatin or vehicle infusion during training. Test memory retrieval with allatostatin or vehicle infusion during testing. Compare four conditions: VEH/VEH, AL/VEH, VEH/AL, AL/AL.
Note: VEH/VEH: 70.0%±5.5% freezing (n=12); AL/VEH: 47.4%±6.4% freezing (n=12); VEH/AL: disrupted freezing; AL/AL: 49.5%±6.6% freezing (n=12), not significantly different from AL/VEH (P>0.05)
“we included an AL manipulation during both training and testing. Consistent with CREB's role in memory consolidation, we found that activation of the HSV-CREB neurons during training enhanced tone-associated fear memory (VEH/VEH, 70.0% ± 5.5%, n = 12); while inactivation of the HSV-CREB neurons with AL during training reduced tone-associated fear memory to control levels”
Test memory allocation 30 minutes after training (before memory consolidation occurs). Infuse allatostatin or vehicle immediately after training and test freezing 30 minutes post-training.
Note: HSV-CREB mice did not show higher freezing than HSV-LacZ mice at 30 min post-training. AL administration immediately after training disrupted 30-min memory in HSV-CREB mice (HSV-CREB/VEH: 50.9%±5.5%, HSV-CREB/AL: 28.9%±5.2%, F3,44=6.93, P<0.05, n=12 per group) but not in HSV-LacZ mice (HSV-LacZ/VEH: 48.1%±7.5%, HSV-LacZ/AL: 52.9%±5.7%)
“we tested memory allocation 30 min after training, a time point known to precede memory consolidation. Indeed, when tested 30 min post-training, HSV-CREB mice did not show higher freezing than HSV-LacZ mice”
Fear condition mice before (not after) viral injection. Three days after viral infection, train same mice on conditioned taste aversion (CTA). Test CTA memory with allatostatin or vehicle infusion.
Note: AL impaired CTA memory (HSV-CREB/VEH: 71.9%±7.7%, HSV-CREB/AL: 50.0%±5.9%, t=2.31, P<0.05) but had no effect on tone fear memory (HSV-CREB/VEH: 50.6%±8.6%, HSV-CREB/AL: 49.9%±9.8%, P>0.05). Total fluid consumption in CTA test was same in different treatment groups.
“we fear conditioned the mice before (and not after) viral injection. Then, we trained the same mice on taste aversion conditioning (CTA) 3 days following viral infection”
Perform whole-cell recordings from thalamo-LA synapses in naive and conditioned mice (24 hours post-training). Measure evoked EPSCs and paired pulse facilitation (PPF) in HSV-CREB neurons and non-transfected neighboring cells.
Note: Fear conditioning potentiates synaptic transmission (F1,37=7.68, P<0.01) and decreases PPF (F1,82=26.35, P<0.001). HSV-CREB neurons in conditioned mice show enhanced synaptic transmission and reduced PPF compared to three control groups (P<0.001).
“we studied synaptic transmission and PPF in HSV-CREB neurons and non-transfected neighboring cells in the same slices in both naive and conditioned mice (24 hrs post-training)”
Prepare acute lateral amygdala slices approximately 3 days after virus infusion. Perform whole-cell recordings to measure action potential threshold, number of action potentials elicited by depolarizing current injections, spike frequency adaptation, and afterhyperpolarization (AHP).
Note: HSV-CREB neurons show: lower AP threshold (-38.8±0.9 mV vs -35.4±1.0 to -35.7±1.0 mV, P<0.05); increased number of action potentials (P<0.05); reduced spike frequency adaptation (62% of HSV-CREB neurons fired >6 spikes vs 19% of control neurons); reduced AHP amplitude at 300 ms after current pulse
“we prepared acute lateral amygdala slices ~3 days after virus infusion and performed whole-cell recordings. We found that although HSV-CREB did not affect the resting membrane potential, input resistance, spike amplitude or the spike half-width of transfected lateral amygdala pyramidal neurons, it did significantly lower the AP threshold of those neurons”
Measure relationship between EPSP slope and spike probability following different synaptic stimulation intensities in HSV-CREB and control neurons.
Note: Determines whether intrinsic excitability changes alter input-output function critical for information processing during learning
“We measured the relationship between the EPSP slope and spike probability following different synaptic stimulation intensities”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
To determine whether inactivation of lateral amygdala neurons transfected with HSV-CREB disrupts auditory fear conditioning memory by measuring freezing behavior during tone presentation
Objective
To determine whether inactivation of lateral amygdala neurons transfected with HSV-CREB disrupts auditory fear conditioning memory by measuring freezing behavior during tone presentation
Subjects
From papermouse • Not specified • Not specified • Not specified • Not specified
Sample count
From paperMultiple groups (n values range from 12-17 per group)
Cohort notes
From paperBilateral cannula placements in basolateral complex of amygdala required for inclusion in analysis
Viral vector preparation and microinjection (~3 days before conditioning)
Cannula placement verification (At end of experiment)
Verify CREB expression increase (Not specified)
Verify selective neuronal silencing by allatostatin (Not specified)
Percentage of time spent freezing during tone presentation (primary behavioral measure of fear memory)
From paperTwo-way ANOVA for fear conditioning effects on synaptic transmission and PPF (F1,37=7.68 for transmission, F1,82=26.35 for PPF); One-way Repeated Measures ANOVA for comparing HSV-CREB neurons across groups (P<0.001); Newman-Keuls Multiple Comparison Test for post-hoc comparisons; Repeat ANOVA analysis for action potential comparisons; Fisher's PLSD test for multiple comparisons; t-tests for individual group comparisons; Chi-square or Fisher's exact test for categorical data (spike firing properties)
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Membrane potential changes in response to allatostatin administration
From paperTwo-way ANOVA for fear conditioning effects on synaptic transmission and PPF (F1,37=7.68 for transmission, F1,82=26.35 for PPF); One-way Repeated Measures ANOVA for comparing HSV-CREB neurons across groups (P<0.001); Newman-Keuls Multiple Comparison Test for post-hoc comparisons; Repeat ANOVA analysis for action potential comparisons; Fisher's PLSD test for multiple comparisons; t-tests for individual group comparisons; Chi-square or Fisher's exact test for categorical data (spike firing properties)
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Spike current threshold changes
From paperTwo-way ANOVA for fear conditioning effects on synaptic transmission and PPF (F1,37=7.68 for transmission, F1,82=26.35 for PPF); One-way Repeated Measures ANOVA for comparing HSV-CREB neurons across groups (P<0.001); Newman-Keuls Multiple Comparison Test for post-hoc comparisons; Repeat ANOVA analysis for action potential comparisons; Fisher's PLSD test for multiple comparisons; t-tests for individual group comparisons; Chi-square or Fisher's exact test for categorical data (spike firing properties)
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Input resistance changes
From paperTwo-way ANOVA for fear conditioning effects on synaptic transmission and PPF (F1,37=7.68 for transmission, F1,82=26.35 for PPF); One-way Repeated Measures ANOVA for comparing HSV-CREB neurons across groups (P<0.001); Newman-Keuls Multiple Comparison Test for post-hoc comparisons; Repeat ANOVA analysis for action potential comparisons; Fisher's PLSD test for multiple comparisons; t-tests for individual group comparisons; Chi-square or Fisher's exact test for categorical data (spike firing properties)
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Percentage of time spent freezing during tone presentation (primary behavioral measure of fear memory)
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Membrane potential changes in response to allatostatin administration
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Spike current threshold changes
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Input resistance changes
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
Two-way ANOVA for fear conditioning effects on synaptic transmission and PPF (F1,37=7.68 for transmission, F1,82=26.35 for PPF); One-way Repeated Measures ANOVA for comparing HSV-CREB neurons across groups (P<0.001); Newman-Keuls Multiple Comparison Test for post-hoc comparisons; Repeat ANOVA analysis for action potential comparisons; Fisher's PLSD test for multiple comparisons; t-tests for individual group comparisons; Chi-square or Fisher's exact test for categorical data (spike firing properties)
Scoring or quantification
Quantify the primary readouts for this experiment: Percentage of time spent freezing during tone presentation (primary behavioral measure of fear memory); Membrane potential changes in response to allatostatin administration; Spike current threshold changes; Input resistance changes.
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for Percentage of time spent freezing during tone presentation (primary behavioral measure of fear memory), Membrane potential changes in response to allatostatin administration, Spike current threshold changes, Input resistance changes.
Source links and direct wording from the methods section for validation and deeper review.
Citation
Yu Zhou et al. (2009). CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala. Nature Neuroscience
Viral vector preparation and microinjection • Protocol step
“These viruses were microinjected into lateral amygdala, which is essential for auditory Pavlovian fear-conditioning. Histological staining with a GFP antibody revealed that ~20% of lateral amygdala neurons were transfected with either virus”
Cannula placement verification • Protocol step
“Cannula placement was confirmed with crystal violet staining at the end of each experiment. Only those mice with bilateral placements in the basolateral complex of the amygdala were included in analysis”
Verify CREB expression increase • Protocol step
“western blot analyses showed that HSV-CREB viral transfection increased CREB levels in the amygdala; Transfection with HSV-LacZ had no detectable effect on CREB expression”
Verify selective neuronal silencing by allatostatin • Protocol step
“AL administration quickly and reversibly caused the membrane potential to become more negative (−5.9 ± 1.2 mV, t = 3.73, P < 0.01) in GFP + neurons, but had no effect on GFP − neighboring cells”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Gather these items before starting the experiment. Check off items as you prepare.
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Picower Institute of MIT (viral preparations provided by R. Neve) • Not specified • Not specified • Not specified
Picower Institute of MIT (viral preparations provided by R. Neve) • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified
2 items with ReplicateScience direct pages
Estimated: $647.00
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Mar 14, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
14
Evidence Quotes
14
Protocol Items
13
Linked Products
2
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Mar 14, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
14
Evidence
14
Specific Products
2/2
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Mar 14, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.